The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
from CNN.com - RSS Channel - App International Edition https://ift.tt/HNSBkoD January 07, 2023 at 01:43AM https://ift.tt/SyCknU0
Home »
CNN.com - RSS Channel - App International Edition
» Alzheimer's drug lecanemab receives accelerated approval in US amid safety concerns
0 $type={blogger}:
Post a Comment